Stockreport

Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference [Yahoo! Finance]

Werewolf Therapeutics, Inc.  (HOWL) 
PDF biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer [Read more]